NCT05962970View on ClinicalTrials.gov

Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 4, 2023

Primary Completion Date

August 3, 2024

Study Completion Date

December 31, 2024

Conditions
Total Knee Arthroplasty
Interventions
DRUG

continuous adductor canal block (CACB) ropivacaine

The CACB group will receive an infusion of 0.2% ropivacaine 5mL/h

DRUG

sham continuous adductor canal block - ShACB NaCl

sham continuous adductor canal block - ShACB and ShACB group will receive an infusion of NaCl 0.9% 5mL/h.

Trial Locations (1)

M5G 1X5

RECRUITING

Mount Sinai Hospital, Toronto, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER